Avior Wealth Management, LLC - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 84 filers reported holding HUMACYTE INC in Q3 2023. The put-call ratio across all filers is 63.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
Avior Wealth Management, LLC ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$2,930
+2.4%
1,0000.0%0.00%
Q2 2023$2,860
-7.4%
1,0000.0%0.00%
Q1 2023$3,090
+46.4%
1,0000.0%0.00%
Q4 2022$2,110
-29.7%
1,0000.0%0.00%
Q3 2022$3,0000.0%1,0000.0%0.00%
Q2 2022$3,000
-57.1%
1,0000.0%0.00%
-100.0%
Q1 2022$7,0000.0%1,0000.0%0.00%0.0%
Q4 2021$7,000
-36.4%
1,0000.0%0.00%0.0%
Q3 2021$11,0001,0000.00%
Other shareholders
HUMACYTE INC shareholders Q3 2023
NameSharesValueWeighting ↓
York Capital Management Global Advisors, LLC 2,291,397$16,613,0003.70%
Monashee Investment Management LLC 399,910$2,899,0000.72%
Endowment Wealth Management, Inc. 96,618$700,0000.71%
Gladstone Institutional Advisory LLC 246,717$1,7890.14%
Diameter Capital Partners LP 300,338$2,177,0000.13%
CenterBook Partners LP 23,706$172,0000.10%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 900,100$6,526,000,0000.06%
Exos Asset Management LLC 16,139$117,0000.06%
Maven Securities LTD 200,000$1,450,0000.04%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 11,000$80,0000.04%
View complete list of HUMACYTE INC shareholders